Riskpilot← Back to searchSign inGet full accessBrilliantiq AB
ABBankruptOrg 5590925649Other non-specialised retail sale · NACE 4712Est. 20160 employees
Revenue 2023
SEK 0
EBITDA margin
—
Equity ratio
7.5%
Financial strength
Net profit 2023
SEK 0
+100% vs 2022
| Revenue | SEK 0 | — |
| EBITDA | — | — |
| Net profit | SEK 0 | +100% |
| Total assets | SEK 3,4M | +0% |
| Equity | SEK 260K | -70% |
| Employees | 0 | — |
Legal name
Brilliantiq AB
Org number
5590925649
Legal form
Aktiebolag
NACE code
4712 · Other non-specialised retail sale
Founded
20 december 2016
Share capital
SEK 52 632
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget skall själva eller genom andra utveckla, tillverka och marknadsföra hälsoprodukter i form av tuggummin.
Address
Email
advokat@dimeo.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 228 | 23 | 88 | 0 | 0 |
| Staff expenses | — | — | — | −0 | −0 |
| EBITDA | −156 | −974 | −891 | −604 | — |
| Depreciation & amort. | −0 | −22 | −22 | — | — |
| EBIT | −156 | −996 | −913 | −604 | 0 |
| Net financials | −15 | −37 | −49 | −4 | — |
| Profit before tax | −171 | −1 034 | −962 | −608 | 0 |
| Tax | −0 | −0 | −0 | — | — |
| Net profit | −171 | −1 034 | −962 | −608 | 0 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 3 231 | 3 744 | 3 637 | 3 446 | 3 446 |
| Equity | 706 | 822 | 868 | 868 | 260 |
| Long-term debt | 1 206 | 1 019 | 1 106 | 1 233 | 1 233 |
| Short-term debt | 917 | 1 500 | 1 260 | 1 551 | 1 551 |
| Total debt | 2 123 | 2 519 | 2 366 | 2 784 | 2 784 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20192023
Equity ratio
7.5%
This company
38.2%
Market median
-80% vs market
20192023
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20192023
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20192023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192023
Debt / equity
12.26×
This company
0.62×
Market median
-1877% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
DB Liquidator | Liquidator | 2025 |
| Former (1) | ||
RM Chief Executive Officer | Chief Executive Officer | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Chairman | 2020 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Brilliantiq AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dag Benjamin Ardino di Meo | Liquidator | 0 companies |
| Roger Magnus Petersson | Chief Executive Officer | 0 companies |
| Robin Einar Petersson | Chairman | 0 companies |